US Patent 10966922 Pharmaceutical formulations

Patent 10966922 was granted and assigned to Auspex Pharmaceuticals, Inc. on April, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

Auspex Pharmaceuticals, Inc.

Current Assignee

‌

Auspex Pharmaceuticals, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10966922

Date of Patent

April 6, 2021

Patent Application Number

16510246

Date Filed

July 12, 2019

Patent Citations

‌

US Patent 10166183 Pharmaceutical formulations

Patent Primary Examiner

‌

Brian J Davis

Patent abstract

The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10966922 Pharmaceutical formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API